TY  - JOUR
AU  - Pabla, Sarabjot
AU  - Conroy, Jeffrey M
AU  - Nesline, Mary K
AU  - Glenn, Sean T
AU  - Papanicolau-Sengos, Antonios
AU  - Burgher, Blake
AU  - Hagen, Jacob
AU  - Giamo, Vincent
AU  - Andreas, Jonathan
AU  - Lenzo, Felicia L
AU  - Yirong, Wang
AU  - Dy, Grace K
AU  - Yau, Edwin
AU  - Early, Amy
AU  - Chen, Hongbin
AU  - Bshara, Wiam
AU  - Madden, Katherine G
AU  - Shirai, Keisuke
AU  - Dragnev, Konstantin
AU  - Tafe, Laura J
AU  - Marin, Daniele
AU  - Zhu, Jason
AU  - Clarke, Jeff
AU  - Labriola, Matthew
AU  - McCall, Shannon
AU  - Zhang, Tian
AU  - Zibelman, Matthew
AU  - Ghatalia, Pooja
AU  - Araujo-Fernandez, Isabel
AU  - Singavi, Arun
AU  - George, Ben
AU  - MacKinnon, Andrew Craig
AU  - Thompson, Jonathan
AU  - Singh, Rajbir
AU  - Jacob, Robin
AU  - Dressler, Lynn
AU  - Steciuk, Mark
AU  - Binns, Oliver
AU  - Kasuganti, Deepa
AU  - Shah, Neel
AU  - Ernstoff, Marc
AU  - Odunsi, Kunle
AU  - Kurzrock, Razelle
AU  - Gardner, Mark
AU  - Galluzzi, Lorenzo
AU  - Morrison, Carl
PY  - 2019
DO  - 10.1186/s40425-019-0506-3
UR  - http://hdl.handle.net/10668/13497
T2  - Journal for immunotherapy of cancer
AB  - Resistance to immune checkpoint inhibitors (ICIs) has been linked to local immunosuppression independent of major ICI targets (e.g., PD-1). Clinical experience with response prediction based on PD-L1 expression suggests that other factors influence...
LA  - en
KW  - Atezolizumab
KW  - Ipilimumab
KW  - Nivolumab
KW  - PD-1
KW  - Pembrolizumab
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Immunological
KW  - B7-H1 Antigen
KW  - Base Sequence
KW  - Biomarkers
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cell Proliferation
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Survival Analysis
TI  - Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.
TY  - research article
VL  - 7
ER  -